FDA Approves Mesenchymal Stem Cell Clinical Trials for COVID-19

FDA Approves Mesenchymal Stem Cell Clinical Trials for COVID-19 1

Pregnancy during Coronavirus Outbreak: Reasons for considering Mesenchymal Stem Cell Therapy for COVID-19     PATHOGENESIS OF COVID-19   Basically, the S protein, on COVID-19, recognises the Angiotensin Converting Enzyme 2 (ACE2) receptor, which is naturally present on the surface or membrane of normal cells of lungs, heart, liver, digestive organs, kidneys, almost all endothelial […]

Continue reading